Arrowhead Pharmaceuticals, Inc.
ARWRNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $8.32B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $36.73$95.49
- Volume (live)
- -
- Avg. volume (3M)
- 2.23M
Arrowhead Pharmaceuticals (ARWR) Stock Price & Financial Analysis
Arrowhead Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $56.56 - $58.40 |
|---|---|
| 52-Week High | $95.49 |
| 52-Week Low | $36.73 |
| Open | $58.15 |
| Volume (last close) | 871.67K |
| Average Volume (3M) | 2.23M |
| Revenue (TTM) | 669.50M |
|---|---|
| Net Income (TTM) | -319.95M |
| Free Cash Flow (TTM) | -75.11M |
| EPS (TTM) | −$2.27 |
| Profit Margin | -47.79% |
| Operating Margin | -33.82% |
| Return on Equity (ROE) | -68.73% |
| Debt to Equity | 1.86 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 8.32B |
|---|---|
| Shares Outstanding | 143.38M |
| Price to Sales (P/S) | 12.43 |
| Price to Book (P/B) | 17.87 |
| EV/EBITDA | -56.47 |
| 50-Day MA | $74.36 |
|---|---|
| 200-Day MA | $72.00 |
| 1-Year Change | +56.25% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Arrowhead Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Arrowhead Pharmaceuticals (ARWR) has a market capitalization of $8.32B. The stock trades at 12.4× sales. Over the trailing twelve months it lost $319.95M on revenue of $669.50M and burned $75.11M of free cash flow. Revenue grew 16.9% year over year.
As of its latest reported balance sheet, it holds $19.68M in cash and securities against $864.07M of debt, a net debt position of $844.39M.
Arrowhead Pharmaceuticals does not currently pay a dividend.
The share price is up 56.3% over the past year. At $58.02 (the Oct 23, 2026 close) it sits within its 52-week range of $36.73 to $95.49, below its 200-day moving average of $72.00.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $109.00, 87.9% above the Oct 23, 2026 close.
Frequently Asked Questions About Arrowhead Pharmaceuticals
What is the current stock price for ARWR?
As of the Oct 23, 2026 close, ARWR stock trades at $58.02. The 52-week range is $36.73–$95.49, with a day range of $56.56–$58.40.
What is the P/E ratio for ARWR?
The P/E ratio (Price-to-Earnings) for ARWR is shown in the Key Statistics section. This valuation metric helps compare Arrowhead Pharmaceuticals, Inc. to industry peers.
Does ARWR pay dividends?
Arrowhead Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ARWR?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for ARWR is Buy. The average 12-month price target is $109.00, a 87.9% upside from the Oct 23, 2026 close of $58.02.
What is the market cap of ARWR?
As of the Oct 23, 2026 close, Arrowhead Pharmaceuticals's market capitalization is $8.32B, classifying it as a mid-cap company. Arrowhead Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.